To access this article: https://www.recoveryanswers.org/research-post/in-person-vs-online-meetings-which-are-better/
In-person versus online meetings: Which are better?

In light of the increased use of online mutual-help group meetings during and after COVID-19, a pressing question remains: are online meetings as helpful as in-person meetings for supporting recovery? This study examined how the two types were associated with participation patterns and alcohol outcomes.
To access this article: https://www.recoveryanswers.org/research-post/can-warning-labels-and-advertising-regulations-work-for-alcohol-way-worked-tobacco/
Can warning labels and advertising regulations work for alcohol the way they’ve worked for tobacco?

Given the enormous public health burden related to alcohol, many countries are moving to restrict alcohol advertising and add health warning labels to alcohol advertisements and products as typically done for tobacco. This study assessed how restricting advertisement context and adding health warning labels influenced perceptions of alcohol and drinking motivation.
To access this article: https://www.recoveryanswers.org/research-post/methamphetamine-use-disorder-addressing-needs-of-family-friends/
Methamphetamine use disorder: Addressing the needs of family and friends

Despite increased risk of secondary harms from a loved one’s substance use, including physical, social, emotional and financial problems, there are few resources available for family and friends. This study pilot tested an 8-week intervention for family and friends of people who use methamphetamines.
To access this article: https://www.recoveryanswers.org/research-post/what-promised-vs-what-delivered-lgbtq-addiction-care/
What is promised versus what gets delivered in LGBTQ addiction care

LGBTQ individuals as a population have higher rates of non-medical prescription opioid use and opioid use disorder relative to the general population. This study characterized how available programs might be that address the unique needs of LGBTQ individuals with opioid use disorder.
To access this article: https://www.recoveryanswers.org/research-post/testing-new-combination-medications-alcohol-use-disorder/
Testing a new combination of medications for alcohol use disorder

Several alcohol use disorder medications have been developed and approved by the FDA, many of which are intended to help individuals who want to quit entirely. This study examined a novel medication treatment tailored specifically for those who want to reduce but not completely eliminate their alcohol use.
To access this article: https://www.recoveryanswers.org/research-post/do-benefits-providing-motivational-incentives-used-contingency-management-stop-youth-cannabis-use-persist-after-theyre-gone/
Do the benefits of providing motivational incentives used in contingency management to stop youth cannabis use persist after they’re gone?

Contingency management is a helpful intervention for treatment-seeking adults with cannabis use problems in which participants receive immediate incentives (e.g., money) for demonstration of a given behavior (e.g., abstinence). This study investigated if a short-term cannabis contingency management intervention for young people not currently seeking treatment led to reduced cannabis use in the weeks after the intervention ended.
To access this article: https://www.recoveryanswers.org/research-post/comparing-opioid-use-disorder-medications-those-with-legal-involvement/
Comparing opioid use disorder medications for those with legal involvement

Opioid use disorder is associated with high rates of criminal-legal involvement. Medications can help but the role of criminal histories in medication engagement and effects has yet to be fully assessed. This study examined the association between criminal-legal involvement and the effects of buprenorphine and extended-release naltrexone.
To access this article: https://www.recoveryanswers.org/research-post/right-drugs-right-route-potential-benefits-safer-drug-supply-program/
“Right drugs, right dose, right route”: The potential benefits of a safer drug supply program

Promoting a safer drug supply through controlled access to regulated drugs is controversial but has the potential to reduce overdose risk and improve public health. This study outlined perspectives of participants in a safer supply program to determine whether the program met their needs.
ABOUT: The Recovery Research Institute is a non-profit research institute of the Massachusetts General Hospital, a teaching hospital of Harvard Medical School.
Twitter Facebook LinkedIn

Share this email:
Email Twitter Facebook LinkedIn
Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.
151 Merrimac Street
Boston, MA | 02114 US
This email was sent to .
To continue receiving our emails, add us to your address book.
powered by emma